Contact
searchSearch
HMP Global

Drug Recalls

The Latest

News
Lacosamide Tablets Recalled Due to the Presence of Foreign Tablets
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
Cinacalcet Tablets Recalled Due to CGMP Deviations
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
BD ChloraPrep Clear and BD ChloraPrep FREPP Clear Recalled Due to Non-Sterility
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for BD ChloraPrep Clear and BD ChloraPrep FREPP Clear due to non-sterility, affecting 371 440 applicators.
The US Food and Drug Administration (FDA) has issued a Class I recall for BD ChloraPrep Clear and BD ChloraPrep FREPP Clear due to non-sterility, affecting 371 440 applicators.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
Focalin XR Recalled Due to Incorrect Labeling
06/25/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for Focalin XR (dexmethylphenidate HCl) due to incorrect labeling, affecting 7803 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for Focalin XR (dexmethylphenidate HCl) due to incorrect labeling, affecting 7803 bottles.
The US Food and Drug...
06/25/2026
Pharmacy Learning Network
News
Chlorthalidone Tablets Recalled Due to Failed Dissolution Specifications
06/25/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for chlorthalidone tablets due to the product’s failure to meet dissolution specifications, affecting 11 460 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for chlorthalidone tablets due to the product’s failure to meet dissolution specifications, affecting 11 460 bottles.
The US Food and Drug...
06/25/2026
Pharmacy Learning Network
News
Aripiprazole Tablets Recalled Due to Product Mix-Up
06/25/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for aripiprazole tablets due to a product mix-up, affecting 6143 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for aripiprazole tablets due to a product mix-up, affecting 6143 bottles.
The US Food and Drug...
06/25/2026
Pharmacy Learning Network
News
Primidone Tablets Recalled Due to Cross Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
Alcohol Sanitizer Spray Recalled Due to Microbial Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
Doxorubicin Hydrochloride Liposome Injections Recalled Due to Foreign Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
Duloxetine Delayed Release Capsules Recalled Due to CGMP Deviations
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
Extra Strength Antacid Calcium Carbonate Recalled Due to Foreign Contamination
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network

Newsfeed

News
Lacosamide Tablets Recalled Due to the Presence of Foreign Tablets
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
Cinacalcet Tablets Recalled Due to CGMP Deviations
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
BD ChloraPrep Clear and BD ChloraPrep FREPP Clear Recalled Due to Non-Sterility
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for BD ChloraPrep Clear and BD ChloraPrep FREPP Clear due to non-sterility, affecting 371 440 applicators.
The US Food and Drug Administration (FDA) has issued a Class I recall for BD ChloraPrep Clear and BD ChloraPrep FREPP Clear due to non-sterility, affecting 371 440 applicators.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
Primidone Tablets Recalled Due to Cross Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
Alcohol Sanitizer Spray Recalled Due to Microbial Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
Doxorubicin Hydrochloride Liposome Injections Recalled Due to Foreign Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
Duloxetine Delayed Release Capsules Recalled Due to CGMP Deviations
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
Extra Strength Antacid Calcium Carbonate Recalled Due to Foreign Contamination
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
Amlodipine and Olmesartan Medoxomil Tablets Recalled Due to Failure to Meet Dissolution Specifications
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
MG217 Treatment Cream and Skin Protectant Recalled Due to Staphylococcus Aureus Contamination
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network
News
Lacosamide Tablets Recalled Due to the Presence of Foreign Tablets
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for lacosamide tablets, 100 mg, due to the presence of foreign tablets, affecting 31 392 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
Cinacalcet Tablets Recalled Due to CGMP Deviations
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for sensipar (cinacalcet) tablets due to Current Good Manufacturing Practice (CGMP) deviations, affecting 9565 bottles.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
News
BD ChloraPrep Clear and BD ChloraPrep FREPP Clear Recalled Due to Non-Sterility
07/02/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for BD ChloraPrep Clear and BD ChloraPrep FREPP Clear due to non-sterility, affecting 371 440 applicators.
The US Food and Drug Administration (FDA) has issued a Class I recall for BD ChloraPrep Clear and BD ChloraPrep FREPP Clear due to non-sterility, affecting 371 440 applicators.
The US Food and Drug...
07/02/2026
Pharmacy Learning Network
PharmLaw
DOJ Telemedicine Fraud Case Underscores Compliance Risks for Health Care Organizations
07/01/2026
Hannah Musick
A US Department of Justice (DOJ) enforcement action against a telemedicine company owner underscores continuing regulatory scrutiny of telemedicine prescribing, kickback arrangements, and Medicare billing practices.
A US Department of Justice (DOJ) enforcement action against a telemedicine company owner underscores continuing regulatory scrutiny of telemedicine prescribing, kickback arrangements, and Medicare billing practices.
A US Department of Justice (DOJ)...
07/01/2026
Pharmacy Learning Network
PharmLaw
PBM Trade Group Challenges Illinois Drug Pricing Transparency Law on ERISA Grounds
06/24/2026
Hannah Musick
The Pharmaceutical Care Management Association has sued Illinois to block key provisions of the state's Prescription Drug Affordability Act, setting up a legal challenge that could shape the future of pharmacy benefit manager (PBM)...
The Pharmaceutical Care Management Association has sued Illinois to block key provisions of the state's Prescription Drug Affordability Act, setting up a legal challenge that could shape the future of pharmacy benefit manager (PBM)...
The Pharmaceutical Care...
06/24/2026
Pharmacy Learning Network
News
Primidone Tablets Recalled Due to Cross Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
Alcohol Sanitizer Spray Recalled Due to Microbial Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
Doxorubicin Hydrochloride Liposome Injections Recalled Due to Foreign Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
PharmLaw
Ahold Delhaize USA to Pay $40 Million in Drug Price Claims Settlement
06/16/2026
Grace Taylor, MS, MA
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay...
06/16/2026
Pharmacy Learning Network
PharmLaw
Federal Court Grants Lilly Preliminary Injunction in $200 Million Drug Rebate Fraud Case
06/11/2026
Hannah Musick
A federal court has granted Eli Lilly a preliminary injunction in its lawsuit alleging a $200 million rebate fraud scheme involving Trulicity, requiring defendants to provide detailed documentation for future rebate claims and signaling...
A federal court has granted Eli Lilly a preliminary injunction in its lawsuit alleging a $200 million rebate fraud scheme involving Trulicity, requiring defendants to provide detailed documentation for future rebate claims and signaling...
A federal court has granted Eli...
06/11/2026
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use